Literature DB >> 10762573

Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.

J Somani1, V B Bhullar, K A Workowski, C E Farshy, C M Black.   

Abstract

In vitro susceptibility testing and genotyping were done on urogenital isolates of Chlamydia trachomatis from 3 patients, 2 of whom showed evidence of clinical treatment failure with azithromycin and one of whom was the wife of a patient. All 3 isolates demonstrated multidrug resistance to doxycycline, azithromycin, and ofloxacin at concentrations >4.0 microg/mL. Recurrent disease due to relapsing infection with the same resistant isolate was documented on the basis of identical genotypes of both organisms. This first report of clinically significant multidrug-resistant C. trachomatis causing relapsing or persistent infection may portend an emerging problem to clinicians and public health officials.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10762573     DOI: 10.1086/315372

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  66 in total

1.  Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae.

Authors:  Paul F Riska; Andrei Kutlin; Patrick Ajiboye; Arnold Cua; Patricia M Roblin; Margaret R Hammerschlag
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 2.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

3.  Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides.

Authors:  O Y Misyurina; E V Chipitsyna; Y P Finashutina; V N Lazarev; T A Akopian; A M Savicheva; V M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

Review 4.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

5.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

6.  Trachoma: ancient scourge, disease elimination, and future research.

Authors:  Charles Knirsch
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

7.  Increased carriage of macrolide-resistant fecal E. coli following mass distribution of azithromycin for trachoma control.

Authors:  Jessica C Seidman; Christian L Coles; Ellen K Silbergeld; Joshua Levens; Harran Mkocha; Lashaunda B Johnson; Beatriz Muñoz; Sheila K West
Journal:  Int J Epidemiol       Date:  2014-03-21       Impact factor: 7.196

Review 8.  Chlamydia trachomatis today: treatment, detection, immunogenetics and the need for a greater global understanding of chlamydial disease pathogenesis.

Authors:  D Dean
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

9.  Tetracycline resistance in Chlamydia suis mediated by genomic islands inserted into the chlamydial inv-like gene.

Authors:  Jae Dugan; Daniel D Rockey; Loren Jones; Arthur A Andersen
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  The laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  Max A Chernesky
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.